The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 341:362-363 July 29, 1999 Number 5
NextNext

Fever and Neutropenia — How to Use a New Treatment Strategy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Freifeld, A.
-Related Article
 by Kern, W. V.
-PubMed Citation
The treatment of fever and neutropenia has evolved with the development of both new antimicrobial drugs and new strategies for using them. More than three decades ago, Bodey and colleagues identified the association between neutropenia and serious infection in patients with cancer as such patients began to be treated with intensive cytotoxic chemotherapy and given platelet transfusions to prevent death from bleeding.1 The first effective treatment for patients with fever and neutropenia was the combination of an antipseudomonal penicillin, carbenicillin, and gentamicin in a strategy of early empirical therapy triggered by fever alone.2 The studies of Pizzo and colleagues refined . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.